Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $8.5200 (-3.78%) ($8.5200 - $8.8900) on Fri. Jun. 9, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.7% (three month average) | RSI | 52 | Latest Price | $8.5200(-3.78%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 0.5% a day on average for past five trading days. | Weekly Trend | BCRX advances 1.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) BND(26%) XLRE(24%) ARKG(22%) SDY(21%) BNDX(20%) | Factors Impacting BCRX price | BCRX will decline at least -1.35% in a week (0% probabilities). VIXM(-26%) VXX(-23%) VCIT(-16%) TLT(-15%) SHY(-15%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -1.35% (StdDev 2.7%) | Hourly BBV | -1.3 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $8.62(-1.16%) | 10 Day Moving Average | $8.42(1.19%) | 20 Day Moving Average | $8.42(1.19%) | To recent high | -3.8% | To recent low | 15.5% | Market Cap | $1.503b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |